Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of cladribine treatment on microglial activation in the CNS
2019-001960-31Phase 4Active
- Sponsor
- Turku PET Centre
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cladribine in multiple sclerosis (MS), sponsored by Turku PET Centre. Started Jul 2019; status: active.
02
Drugs
cladribine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2019-001960-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001960-31.